Logo image
Retrotransposons in the development and progression of amyotrophic lateral sclerosis
Journal article   Open access   Peer reviewed

Retrotransposons in the development and progression of amyotrophic lateral sclerosis

A.L. Savage, G.G. Schumann, G. Breen, V.J. Bubb, A. Al-Chalabi and J.P. Quinn
Journal of Neurology, Neurosurgery & Psychiatry, Vol.90(3), pp.284-293
2019
pdf
Retrotransposons in the development and progression of amyotrophic lateral sclerosis.pdfDownloadView
Published (Version of Record)CC BY V4.0 Open Access
url
Free to Read *No subscription requiredView

Abstract

Endogenous retrotransposon sequences constitute approximately 42% of the human genome, and mobilisation of retrotransposons has resulted in rearrangements, duplications, deletions, novel transcripts and the introduction of new regulatory domains throughout the human genome. Both germline and somatic de novo retrotransposition events have been involved in a range of human diseases, and there is emerging evidence for the modulation of retrotransposon activity during the development of specific diseases. Particularly, there is unequivocal consensus that endogenous retrotransposition can occur in neuronal lineages. This review addresses our current knowledge of the different mechanisms through which retrotransposons might influence the development of and predisposition to amyotrophic lateral sclerosis.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

13 File views/ downloads
27 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.54 Molecular & Cell Biology - Genetics
1.54.1122 Transposable Elements
Web Of Science research areas
Clinical Neurology
Psychiatry
Surgery
ESI research areas
Clinical Medicine
Logo image